Park, Chae Gyu http://orcid.org/0000-0003-1906-1308
Chu, Min Kyung http://orcid.org/0000-0001-6221-1346
Funding for this research was provided by:
National Research Foundation of Korea (NRF) grant from the Korean government (2019R1F1A1053841)
Article History
Received: 27 January 2022
Accepted: 4 April 2022
First Online: 28 April 2022
Competing interests
: Min Kyung Chu was a site investigator for a multicenter trial sponsored by Otsuka Korea, Novartis, International AG, and Eli Lilly and Co. He also worked as an advisory member for Teva, and has received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company within the past 24 months. Furthermore, he received grants from the Yonsei University College of Medicine (2018–32-0037) and the National Research Foundation of Korea (2019R1F1A1053841). Chae Gyu Park declares no competing interests.